Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xavier Muracciole

Showing results (51-60 of 61) with videos related to

Pageof 7
Sort By:
Breast Cancer Research and Treatment|September 22, 2018
Isolated ipsilateral local recurrence of breast cancer: predictive factors and prognostic impactGilles Houvenaeghel, Alexandre de Nonneville, Monique Cohen, et al.
International Journal of Radiation Oncology, Biology, Physics|June 2, 2005
Conformal radiotherapy, reduced boost volume, hyperfractionated radiotherapy, and online quality control in standard-risk medulloblastoma without chemotherapy: results of the French M-SFOP 98 protocolChristian Carrie, Xavier Muracciole, Frédéric Gomez, et al.
European Journal of Cancer (Oxford, England : 1990)|December 3, 2014
Multicentre randomised phase II trial of gemcitabine+platinum, with or without trastuzumab, in advanced or metastatic urothelial carcinoma overexpressing Her2Stéphane Oudard, Stéphane Culine, Yann Vano, et al.
Cancers|March 3, 2021
Outcome of Stage IV Completely Necrotic Wilms Tumour and Local Stage III Treated According to the SIOP 2001 ProtocolRaquel Dávila Fajardo, Rhoikos Furtwängler, Martine van Grotel, et al.
Clinical and Translational Radiation Oncology|January 6, 2022
A prospective behavioral and imaging study exploring the impact on long-term memory of radiotherapy delivered for a brain tumor in childhood and adolescenceEloïse Baudou, Jérémie Pariente, Patrice Péran, et al.
Breast Cancer Research and Treatment|February 4, 2017
Benefit of adjuvant chemotherapy with or without trastuzumab in pT1ab node-negative human epidermal growth factor receptor 2-positive breast carcinomas: results of a national multi-institutional studyAlexandre de Nonneville, Anthony Gonçalves, Christophe Zemmour, et al.
The Lancet. Child & Adolescent Health|October 17, 2020
The SIOP-Renal Tumour Study Group consensus statement on flank target volume delineation for highly conformal radiotherapyGeert O Janssens, Patrick Melchior, Joeri Mul, et al.
International Journal of Radiation Oncology, Biology, Physics|February 28, 2018
Hippocampal Sparing During Craniospinal Irradiation: What Did We Learn About the Incidence of Perihippocampus Metastases?Laetitia Padovani, Frédérique Chapon, Nicolas André, et al.
International Journal of Radiation Oncology, Biology, Physics|August 14, 2018
Pediatric Localized Intracranial Ependymomas: A Multicenter Analysis of the Société Française de lutte contre les Cancers de l'Enfant (SFCE) from 2000 to 2013Anne Ducassou, Laetitia Padovani, Leonor Chaltiel, et al.
JAMA Oncology|February 1, 2019
Effect of Adding Docetaxel to Androgen-Deprivation Therapy in Patients With High-Risk Prostate Cancer With Rising Prostate-Specific Antigen Levels After Primary Local Therapy: A Randomized Clinical TrialStéphane Oudard, Igor Latorzeff, Armelle Caty, et al.
Pageof 7

Showing results (51-60 of 61) with videos related to

Sort By:
Pageof 7
Breast Cancer Research and Treatment|September 22, 2018
Isolated ipsilateral local recurrence of breast cancer: predictive factors and prognostic impactGilles Houvenaeghel, Alexandre de Nonneville, Monique Cohen, et al.
International Journal of Radiation Oncology, Biology, Physics|June 2, 2005
Conformal radiotherapy, reduced boost volume, hyperfractionated radiotherapy, and online quality control in standard-risk medulloblastoma without chemotherapy: results of the French M-SFOP 98 protocolChristian Carrie, Xavier Muracciole, Frédéric Gomez, et al.
European Journal of Cancer (Oxford, England : 1990)|December 3, 2014
Multicentre randomised phase II trial of gemcitabine+platinum, with or without trastuzumab, in advanced or metastatic urothelial carcinoma overexpressing Her2Stéphane Oudard, Stéphane Culine, Yann Vano, et al.
Cancers|March 3, 2021
Outcome of Stage IV Completely Necrotic Wilms Tumour and Local Stage III Treated According to the SIOP 2001 ProtocolRaquel Dávila Fajardo, Rhoikos Furtwängler, Martine van Grotel, et al.
Clinical and Translational Radiation Oncology|January 6, 2022
A prospective behavioral and imaging study exploring the impact on long-term memory of radiotherapy delivered for a brain tumor in childhood and adolescenceEloïse Baudou, Jérémie Pariente, Patrice Péran, et al.
Breast Cancer Research and Treatment|February 4, 2017
Benefit of adjuvant chemotherapy with or without trastuzumab in pT1ab node-negative human epidermal growth factor receptor 2-positive breast carcinomas: results of a national multi-institutional studyAlexandre de Nonneville, Anthony Gonçalves, Christophe Zemmour, et al.
The Lancet. Child & Adolescent Health|October 17, 2020
The SIOP-Renal Tumour Study Group consensus statement on flank target volume delineation for highly conformal radiotherapyGeert O Janssens, Patrick Melchior, Joeri Mul, et al.
International Journal of Radiation Oncology, Biology, Physics|February 28, 2018
Hippocampal Sparing During Craniospinal Irradiation: What Did We Learn About the Incidence of Perihippocampus Metastases?Laetitia Padovani, Frédérique Chapon, Nicolas André, et al.
International Journal of Radiation Oncology, Biology, Physics|August 14, 2018
Pediatric Localized Intracranial Ependymomas: A Multicenter Analysis of the Société Française de lutte contre les Cancers de l'Enfant (SFCE) from 2000 to 2013Anne Ducassou, Laetitia Padovani, Leonor Chaltiel, et al.
JAMA Oncology|February 1, 2019
Effect of Adding Docetaxel to Androgen-Deprivation Therapy in Patients With High-Risk Prostate Cancer With Rising Prostate-Specific Antigen Levels After Primary Local Therapy: A Randomized Clinical TrialStéphane Oudard, Igor Latorzeff, Armelle Caty, et al.
Pageof 7